ELEV Elevation Oncology Inc.: Earnings per share for the trailing year

elevationoncology.com (ELEV) - corporate logo

Elevation Oncology develops innovative ADC drugs targeting HER3 tumors, relying on strict temperature control for the air delivery of biocomponents. The relative YoY (TTM) change in EPS demonstrates profit dynamics, where 41.60 indicates the current level. The success of these developments is based on the synergy between the expert community and scientists aiming for a breakthrough in the treatment of rare cancer mutations.

Elevation Oncology, Inc. (ELEV): Net earnings per share (EPS TTM) from 02/11/2024 to 02/20/2024

Elevation Oncology Inc. - analytical breakdowns and key metrics (ELEV)

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental valuation:Elevation Oncology, Inc. - ELEV
Flagship merchandise of Elevation Oncology, Inc.

Long-term investing requires strict monitoring of assets' fundamental stability to minimize risks. For Elevation Oncology (ELEV), this is directly linked to the effectiveness of genetic analysis and the stability of R&D funding. The annual EPS growth for the trailing twelve months reflects the percentage change in net income per share relative to the same period last year. This indicator measures the actual growth rate of business profitability. A positive trend confirms the successful monetization of therapeutic innovations.

Competitor analysis for Elevation Oncology

Earnings per share for the trailing year ONC (BeiGene)|Halozyme Inc. (HALO) - Earnings per share for the last twelve months|RevMed - Earnings per share for the trailing year|AAPG (Ascentage Pharma Group International) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CG Oncology, Inc. CGON|Net earnings per share for the last 12 months URGN (urogen.com)|Earnings per share for the last twelve months BCAX (Bicara Therapeutics)|Net earnings per share (EPS TTM) PSNL (personalis.com)|Earnings per share for the trailing year ERAS|DCTH - Earnings per share for the last twelve months|Y-mAbs Therapeutics (YMAB) - Net earnings per share for the last 12 months|AURA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CADL|Earnings per share for the last twelve months Accuray Inc.|SELLAS Life Sciences Group (SLS) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ACTU (Actuate Therapeutics, Inc)|Net earnings per share for the last four quarters Citius Oncology|TuHURA Biosciences, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Protara TARA|fatetherapeutics.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aadi Bioscience|TCRX: Net earnings per share (EPS TTM)|CSBR - Net earnings per share for the last four quarters|XBIT (XBiotech) - Net earnings per share (EPS TTM)|CVM: Earnings per share for the trailing year|Net earnings per share (EPS TTM) OSTX|RADX (Radiopharm Theranostics Limited) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ARTV (Artiva Biotherapeutics, Inc.)|Earnings per share for the trailing year ANL|VERU: Net earnings per share for the last 12 months|TPST - Net earnings per share (EPS TTM)|XLO (xiliotx.com) - Net earnings per share for the last 12 months|Renovaro Biosciences - Earnings per share for the trailing year|Net earnings per share for the last 12 months MURA|Earnings per share for the last twelve months KAPA|Net earnings per share for the last 12 months OKUR (OnKure Therapeutics Inc)|Net earnings per share (EPS TTM) CytoMed (GDTC)|Earnings per share for the last twelve months curis.com CRIS|APLM (Apollomics, Inc.) - Earnings per one share for the last 12 months|Tharimmune Corporation - Net earnings per share (EPS TTM)|ADVB (advanbiomed.com) - Earnings per share for the last 12 months|Genprex, Inc (GNPX) - Earnings per share for the last twelve months|CLDI: Earnings per share for the last four quarters|SBFM (Sunshine Biopharma, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months XBIO (Xenetic Biosciences)|Net earnings per share (EPS TTM) SLRX|Purple Biotech - Earnings per share for the last 12 months|American Oncology Network - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGNE|CKPT - Earnings per share for the last twelve months|Earnings per share for the trailing year ICAD (icadmed.com)|IKNA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months NTBL|VIRX (viracta.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months MorphoSys Inc MOR|Earnings per share for the last twelve months NAYA Bio (NAYA)|AAPGV: Earnings per one share for the last 12 months